This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hood S et al. (2005) Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med 5: 55–60
Milliez P et al. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45: 1243–1248
Nishimura M et al. (1999) Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 33: 261–266
Sechi LA et al. (2006) Long-term outcomes in patients with primary aldosteronism. JAMA 295: 2638–2645 [erratum JAMA (2006) 296: 1842]
Mattsson C and Young WF Jr (2006) Primary aldosteronism: diagnostic and treatment stategies. Nat Clin Pract Nephrol 2: 198–208
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Fine, L. Primary aldosteronism: renal effects compared with primary hypertension. Nat Rev Nephrol 3, 70–71 (2007). https://doi.org/10.1038/ncpneph0374
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0374